Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Hospira UK Limited, Horizon, Honey Lane., Hurley, Maidenhead, SL6 6RJ, UK
Atracurium Besilate 10 mg/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. A clear colourless or faint yellow solution. |
Atracurium besilate 10 mg/ml (equivalent to atracurium 7.5 mg/ml).
2.5 ml of solution contains 25 mg atracurium besilate.
5 ml of solution contains 50 mg atracurium besilate.
25 ml of solution contains 250 mg atracurium besilate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Atracurium besilate |
Atracurium besilate is a non-depolarising neuromuscular blocking agent with an intermediate duration of action, administered intravenously to produce skeletal muscle relaxation. |
| List of Excipients |
|---|
|
Benzenesulphonic acid |
2.5 ml: Type I glass ampoule in packs of 5 ampoules.
5 ml: Type I glass ampoule in packs of 5 ampoules.
25 ml: Type I glass vial with rubber stopper in packs of 1 vial.
Hospira UK Limited, Horizon, Honey Lane., Hurley, Maidenhead, SL6 6RJ, UK
PL 04515/0099
15 October 1996/14 October 2006
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
